arrow
P

Paolo Ragonese

University of Palermo
H指数:39
被引数:4,258

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patients

2024年脑脊液阳性标准下κ游离轻链指数在多发性硬化中的诊断价值:一项在寡克隆带阴性患者中的多中心研究

2026-11-080
OA
The NeuroEpiTool—A digital tool to ascertain neurological outcomes in population-based studies

神经流行病学工具—一种用于确定基于人群研究中的神经学结局的数字化工具

2026-10-250
OAAI
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)

评估接受不同治疗方案序列治疗的视神经脊髓炎患者队列中长期严重不良事件风险的概况:意大利视神经脊髓炎及相关疾病登记研究(I-MS&RD)(ProSA研究)结果

2026-07-040
PRE
Organisational impact and patient management models for biomarker integration in multiple sclerosis care in Italy: the 0Tolerance project

组织影响及意大利多发性硬化护理中生物标志物整合的患者管理模型:0Tolerance项目

2025-10-090
OA
Shed Syndecans (1-3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson's Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel

分泌型 Syndecans (1-3)、ELA-32、BDNF、NLR 和 hs-CRP 在帕金森病中的研究:当这些生物标志物组合在一个独特面板中时,可作为适当的诊断和预后生物标志物。

2025-05-080
OA
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy

怀孕期间暴露于富马酸二甲酯的多发性硬化症妇女的意大利多中心队列的母婴结局

2024-09-120
PRE
High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patients

高强度间歇训练可改善多发性硬化症患者的骨骼重塑,脂质分布和身体功能

2024-07-132
OAAI
Efficacy and Safety of Rescue Treatment with Plasma Exchange in Patients with Acute Inflammatory Neurological Disorders: A Single Center Experience

血浆置换作为急性炎症性神经系统疾病患者抢救治疗的有效性和安全性:单中心经验

2024-07-100
OAAI
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

那他珠单抗治疗继发性进行性多发性硬化的长期疗效: 一项倾向匹配研究

2024-07-011
OAAI